Nephros, Inc.
NEPH
$5.29
-$0.12-2.22%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.81% | -9.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.81% | -9.39% | |||
| Cost of Revenue | 13.85% | -5.75% | |||
| Gross Profit | 4.29% | -11.38% | |||
| SG&A Expenses | 1.27% | -2.35% | |||
| Depreciation & Amortization | -2.86% | -10.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.69% | -3.25% | |||
| Operating Income | 26.61% | -56.18% | |||
| Income Before Tax | 38.21% | -55.91% | |||
| Income Tax Expenses | -66.67% | -- | |||
| Earnings from Continuing Operations | 42.19% | -57.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 42.19% | -57.53% | |||
| EBIT | 26.61% | -56.18% | |||
| EBITDA | 23.84% | -53.63% | |||
| EPS Basic | 41.96% | -57.41% | |||
| Normalized Basic EPS | 37.93% | -55.93% | |||
| EPS Diluted | 50.00% | -60.00% | |||
| Normalized Diluted EPS | 35.21% | -56.84% | |||
| Average Basic Shares Outstanding | 0.11% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.11% | 1.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||